Pathology News
Lunit said Tuesday that it has published research showing that its AI biomarker platform, Lunit SCOPE, can improve HER2 (human epidermal growth factor receptor 2) diagnosis in advanced bile duct cancer. The study was published in Laboratory...
From the blog at Indica Labs As we reach the end of 2025, the Indica Labs team extends our sincere thanks to the customers and collaborators who helped make this year one of remarkable innovation, growth, and scientific achievement. We are...
Albuquerque, NM, December 17, 2025 – Indica Labs, the global leader in AI-powered digital pathology, announced today that clinical revenue for HALO AP® is up 260% since 2023 and recurring revenue for 2025 shows a 200% increase...
Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology products in two Daiichi Sankyo oncology research and development programs SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ -- Lunit (KRX:328130),...
From Indica Labs: Spatial analysis of the tumor microenvironment provides critical insight into how cancer, immune, and stromal cells interact, helping researchers better understand disease behavior and therapeutic response. Indica Labs’...
The latest from the blog at Indica Labs As scientists work to continue unraveling the structural, cellular, and molecular complexities of the brain and its diseases, the characteristics of this unique tissue pose significant challenges...
